Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-01-18 4:28 pm Sale | 13G | SYNAPTOGENIX INC PAR $0.00 SNPX | HAYWOOD GEORGE WEAVER | 0 0.000% | -485,000 (Position Closed) | View |
| 2022-02-10 2:46 pm Sale | 13G | PETROS PHARMACEUTICALS INC PTPI | HAYWOOD GEORGE WEAVER | 45,000 0.200% | -971,231 (-95.57%) | View |
| 2022-02-10 2:45 pm Purchase | 13G | SYNAPTOGENIX INC PAR $0.00 SNPX | HAYWOOD GEORGE WEAVER | 485,000 7.000% | 485,000 (New Position) | View |
| 2021-10-27 09:47 am Purchase | 13G | PETROS PHARMACEUTICALS INC PTPI | HAYWOOD GEORGE WEAVER | 1,016,231 7.600% | 1,016,231 (New Position) | View |
| 2021-02-11 6:16 pm Purchase | 13G | SYNAPTOGENIX INC PAR $0.00 SNPX | HAYWOOD GEORGE WEAVER | 1,443,440 9.700% | 1,443,440 (New Position) | View |
| 2020-02-13 11:32 am Sale | 13G | ACASTI PHARMA INC DEL COM ACST | HAYWOOD GEORGE WEAVER | 1,801,831 2.100% | -5,595,075 (-75.64%) | View |
| 2020-02-12 11:11 am Sale | 13G | Neurotrope Inc. NTRP | HAYWOOD GEORGE WEAVER | 1,025,271 7.800% | -124,729 (-10.85%) | View |